These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9080596)

  • 1. Immunoreactivity of a new generation of horse F(ab')2 preparations against European viper venoms and the tetanus toxin.
    Pépin-Covatta S; Lutsch C; Grandgeorge M; Scherrmann JM
    Toxicon; 1997 Mar; 35(3):411-22. PubMed ID: 9080596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical assessment of immunoreactivity of a new purified equine F(ab')2 against European viper venom.
    Pepin-Covatta S; Lutsch C; Lang J; Scherrmann JM
    J Pharm Sci; 1998 Feb; 87(2):221-5. PubMed ID: 9519157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Snake F(ab')2 antivenom from hyperimmunized horse: pharmacokinetics following intravenous and intramuscular administrations in rabbits.
    Pepin S; Lutsch C; Grandgeorge M; Scherrmann JM
    Pharm Res; 1995 Oct; 12(10):1470-3. PubMed ID: 8584483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous
    Kurtović T; Karabuva S; Grenc D; Dobaja Borak M; Križaj I; Lukšić B; Halassy B; Brvar M
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33919927
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of 125I-labelled Walterinnesia aegyptia venom and its distribution of the venom and its toxin versus slow absorption and distribution of IGG, F(AB')2 and F(AB) of the antivenin.
    Ismail M; Abd-Elsalam MA; Al-Ahaidib MS
    Toxicon; 1998 Jan; 36(1):93-114. PubMed ID: 9604285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactivity and pharmacokinetics of horse anti-scorpion venom F(ab')2-scorpion venom interactions.
    Pépin-Covatta S; Lutsch C; Grandgeorge M; Lang J; Scherrmann JM
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):272-7. PubMed ID: 8917700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies.
    Welfringer F; d'Athis P; Scherrmann JM; Hervé F
    J Immunol Methods; 2005 Dec; 307(1-2):82-95. PubMed ID: 16305797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption and elimination of viper venom after antivenom administration.
    Rivière G; Choumet V; Saliou B; Debray M; Bon C
    J Pharmacol Exp Ther; 1998 May; 285(2):490-5. PubMed ID: 9580588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of the lyophilized F(ab')2 fragments of horse tetanus antibodies isolated by affinity chromatography.
    Goch H; Schiller B; Korbecki M
    Arch Immunol Ther Exp (Warsz); 1979; 27(4):499-509. PubMed ID: 42372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of F(ab')2 anti-snake venom by caprylic acid: a fast method for obtaining IgG fragments with high neutralization activity, purity and yield.
    dos Santos MC; D'Império Lima MR; Furtado GC; Colletto GM; Kipnis TL; Dias da Silva W
    Toxicon; 1989; 27(3):297-303. PubMed ID: 2728022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of kinin-releasing enzymes from viperid venoms by antivenom IgG fragments.
    al-Joufi A; Bailey GS; Reddi K; Smith DC
    Toxicon; 1991; 29(12):1509-11. PubMed ID: 1801327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of Fc fragment of monoclonal antibodies to tetanus toxin neutralization.
    Ghotloo S; Amiri MM; Khoshnoodi J; Abbasi E; Jeddi-Tehrani M; Golsaz-Shirazi F; Shokri F
    Neurotox Res; 2020 Mar; 37(3):578-586. PubMed ID: 31721050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits: toward an optimization of antivenom therapy.
    Rivière G; Choumet V; Audebert F; Sabouraud A; Debray M; Scherrmann JM; Bon C
    J Pharmacol Exp Ther; 1997 Apr; 281(1):1-8. PubMed ID: 9103473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Snake antivenoms from hyperimmunized horses: comparison of the antivenom activity and biological properties of their whole IgG and F(ab')2 fragments.
    Morais JF; de Freitas MC; Yamaguchi IK; dos Santos MC; da Silva WD
    Toxicon; 1994 Jun; 32(6):725-34. PubMed ID: 7940578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and preclinical evaluation of a new F(ab')₂ antitoxin against botulinum neurotoxin serotype A.
    Yu YZ; Zhang SM; Wang WB; Du Y; Zhu HQ; Wang RL; Zhou XW; Lin JB; Wang S; Yu WY; Huang PT; Sun ZW
    Biochimie; 2010 Oct; 92(10):1315-20. PubMed ID: 20600570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar effectiveness of Fab and F(ab')2 antivenoms in the neutralization of hemorrhagic activity of Vipera berus snake venom in mice.
    Lomonte B; León G; Hanson LA
    Toxicon; 1996 Oct; 34(10):1197-202. PubMed ID: 8931261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of horse F(ab')
    Squaiella-Baptistão CC; Magnoli FC; Marcelino JR; Sant'Anna OA; Tambourgi DV
    J Venom Anim Toxins Incl Trop Dis; 2018; 24():16. PubMed ID: 29946337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between IgG and F(ab')(2) polyvalent antivenoms: neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions.
    León G; Monge M; Rojas E; Lomonte B; Gutiérrez JM
    Toxicon; 2001 Jun; 39(6):793-801. PubMed ID: 11137538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ability of horse anti-Tityus discrepans F(ab')2 ELISA assay to recognize Tityus discrepans venom toxins.
    Díaz P; D'Suze G; Sevcik C
    Toxicon; 2014 Sep; 88():88-92. PubMed ID: 24932739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of quality, safety, and pre-clinical toxicity of an equine polyvalent anti-snake venom (Pan Africa): Determination of immunological cross-reactivity of antivenom against venom samples of Elapidae and Viperidae snakes of Africa.
    Patra A; Kalita B; Mukherjee AK
    Toxicon; 2018 Oct; 153():120-127. PubMed ID: 30189243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.